Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	7.25	69.76	65.04
Graham Fair Price	-54.25	5.59	12.21
PEG	1320.68	0.04	< 0.005
Price/Book	-60.39	0.11	0.27
Price/Cash Flow	-35.06	5.97	9.20
Prices/Earnings	-86.73	-2.97	-1.59
Price/Sales	-55.00	1.80	4.00
Price/FCF	-35.06	5.97	9.20
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.89	0.78	0.80
Operating Margin	-49.00	0.30	-0.58
ROA	78.10	< 0.005	< 0.005
ROE	-0.04	< 0.005	78.79
ROIC	< 0.005	< 0.005	-49.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	< 0.005	-788.81
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-3.40	1.44	-57.56
EPS QOQ	-6.03	0.79	-86.86
FCF QOQ	4.37	-0.40	-90.93
Revenue QOQ	0.30	-0.13	-57.32
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.74	0.72	-1.95
Quick Ratio	1.15	0.30	-74.19
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.46	12.38	-0.66
Cash	10.46	1.73	-83.42
Capex	< 0.005	< 0.005	-96.96
Free Cash Flow	0.37	0.22	-39.41
Revenue	0.84	0.74	-12.56
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.06	1.20	12.85
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	59.07	66.88	13.21
Naive Interpretation	Member

06 - Financial Health · Bad

Rating